Skip to main content
Clinical Trials/ACTRN12611000271909
ACTRN12611000271909
Not yet recruiting
未知

Oesophageal capsule assessment of gastroesophageal reflux disease in chronic lung disease patients awaiting lung transplant and lung transplant recipients.

GIVEN Imaging Australia (supply of video capsules)0 sites100 target enrollmentMarch 15, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
GIVEN Imaging Australia (supply of video capsules)
Enrollment
100
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
GIVEN Imaging Australia (supply of video capsules)

Eligibility Criteria

Inclusion Criteria

  • Patients awaiting lung transplantation or recipients of lung transplantation.

Exclusion Criteria

  • Have difficulty swallowing or have a known oesophageal diverticulum or stricture.
  • Are pregnant or are planning pregnancy in next 6 weeks.
  • Are under 18 years of age.
  • Are unable to give valid informed consent.
  • Have a cardiac pacemakers or defibrillator.
  • Have suffered previous episodes of bowel obstruction: other than non\-mechanical obstruction in patients with cystic fibrosis.
  • Plan to have a MRI (magnetic resonance imaging) scan of any part of the body in the next 8 weeks.

Outcomes

Primary Outcomes

Not specified

Similar Trials